Evidence map›Paper›PMID 24285838›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages.

Poonam Kothari, Roberto Pestana, Rim Mesraoua, Rim Elchaki, K M Faisal Khan, Andrew J Dannenberg, Domenick J Falcone

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 134 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. TRPM2 is a direct pain transducer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Tear cytokine profiles between children with allergic conjunctivitis at varying eye rubbing frequencies and keratoconus: A cross-sectional study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Poonam KothariDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065;
Roberto Pestana
Rim Mesraoua
Rim Elchaki
K M Faisal Khan
Andrew J Dannenberg
Domenick J Falcone
Cornell University · US

Funding

PGE2 receptors: therapeutic targets in occlusive and aneurysmal vascular diseasesR01HL093331 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI FALCONE, DOMENICK J · 2010 to 2013
$1.7M
NHLBI NIH HHS HL093331NHLBI NIH HHS R01 HL093331
6 · The paper itself

Abstract

The mechanisms by which IL-6 contributes to the pathogenesis of chronic inflammatory diseases and cancer are not fully understood. We previously reported that cyclooxygenase-2 (Cox-2)-dependent PGE2 synthesis regulates macrophage matrix metalloproteinase (MMP)-9 expression, an endopeptidase that participates in diverse pathologic processes. In these studies, we determined whether IL-6 regulates the Cox-2→PGE2→MMP-9 pathway in murine macrophages. IL-6 coinduced Cox-2 and microsomal PGE synthase-1, and inhibited the expression of 15-hydroxyprostaglandin dehydrogenase, leading to increased levels of PGE2. In addition, IL-6 induced MMP-9 expression, suggesting that the observed proteinase expression was regulated by the synthesis of PGE2. However, inhibition of PGE2 synthesis partially suppressed IL-6-mediated induction of MMP-9. In the canonical model of IL-6-induced signaling, JAK activation triggers STAT and MAPK(erk1/2)-signaling pathways. Therefore, the ability of structurally diverse JAK inhibitors to block IL-6-induced MMP-9 expression was examined. Inhibition of JAK blocked IL-6-induced phosphorylation of STAT3, but failed to block the phosphorylation of MAPK(erk1/2), and unexpectedly enhanced MMP-9 expression. In contrast, MEK-1 inhibition blocked IL-6-induced phosphorylation of MAPK(erk1/2) and MMP-9 expression without affecting the phosphorylation of STAT3. Thus, IL-6-induced MMP-9 expression is dependent on the activation of MAPK(erk1/2) and is restrained by a JAK-dependent gene product. Using pharmacologic and genetic approaches, we identified JAK-dependent induction of IL-10 as a potent feedback mechanism controlling IL-6-induced MMP-9 expression. Together, these data reveal that IL-6 induces MMP-9 expression in macrophages via Cox-2-dependent and -independent mechanisms, and identifies a potential mechanism linking IL-6 to the pathogenesis of chronic inflammatory diseases and cancer.

Indexed as

AnimalsCell LineCyclooxygenase 2DinoprostoneExtracellular Signal-Regulated MAP KinasesGene Expression RegulationHydroxyprostaglandin DehydrogenasesInterleukin-10Interleukin-6Intramolecular OxidoreductasesJanus KinasesMacrophagesMatrix Metalloproteinase 9MiceModels, BiologicalPiperidines15-hydroxyprostaglandin dehydrogenaseCyclooxygenase 2DinoprostoneExtracellular Signal-Regulated MAP KinasesHydroxyprostaglandin DehydrogenasesInterleukin-10Interleukin-6Intramolecular OxidoreductasesJanus KinasesMatrix Metalloproteinase 9PiperidinesProstaglandin-E SynthasesPtges protein, mousePyrimidinesPyrrolestofacitinib

Identifiers

PMID24285838
PMCPMC3872272
OpenAlexW1911382233

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.